Clinic
Upmc Magee-Womens Hospital
Upmc Magee-Womens Hospital was paid $68K by Medicaid between Oct 2020 and Dec 2024, across 45 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 45% of everything it billed.
33Billing provider infoUPMC MAGEE-WOMENS HOSPITAL
PITTSBURGH, PA 15213
PITTSBURGH, PA 15213
33aNPI1659435501assigned 12/21/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$68K
24GClaims38,637
24DCodes billed45
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Pennsylvania
Rank by total paid#53 of 119
Median peer was paid$57K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 447 | $2K | |
| 2021 | 4,069 | $19K | |
| 2022 | 6,514 | $10K | |
| 2023 | 11,501 | $11K | |
| 2024incomplete | 16,106 | $27K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 45% | 756 | 685 | $31K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 24% | 59 | 59 | $16K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 264 | 229 | $10K |
| 81003 | 4.6% | 1,081 | 964 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.1% | 75 | 69 | $3K |
| J3490 | Unclassified drugs | 2.1% | 4,415 | 1,969 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 252 | 224 | $991.55 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 125 | 98 | $661.44 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 25 | 24 | $593.70 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | 24 | $468.60 |
| 86850 | <1% | 84 | 80 | $341.20 | |
| 86901 | <1% | 97 | 92 | $249.27 |
33 more codes
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,491 | $214.87 |
| 86900 | <1% | 84 | $166.34 | |
| 80053 | Comprehensive metabolic panel | <1% | 20 | $154.94 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $113.60 |
| 84703 | <1% | 13 | $79.03 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,796 | $74.45 |
| 81025 | <1% | 14 | $39.60 | |
| J2704 | Injection, propofol, 10 mg | <1% | 5,853 | $36.66 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 56 | $15.06 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,015 | $14.15 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,016 | $8.05 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,319 | $7.42 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,280 | $4.16 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,388 | $4.04 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 649 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,376 | $0.00 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 0% | 493 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 0% | 531 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 823 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 149 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 30 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 214 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 131 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 146 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 252 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 14 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 44 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 719 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 2,114 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 27 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 174 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 119 | $0.00 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIMMONS, EILEEN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Upmc Magee-Womens Hospital | Pittsburgh, PA | $43.08M |
| Upmc Mercy | Pittsburgh, PA | $16.68M |
| Sutherland Family Practice INC. | Sutherland, VA | $11K |
| Upmc Mercy | Pittsburgh, PA | $326.70 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.